CN114366816B - 一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用 - Google Patents
一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN114366816B CN114366816B CN202210009248.9A CN202210009248A CN114366816B CN 114366816 B CN114366816 B CN 114366816B CN 202210009248 A CN202210009248 A CN 202210009248A CN 114366816 B CN114366816 B CN 114366816B
- Authority
- CN
- China
- Prior art keywords
- chitosan
- freeze
- drying
- nanoparticle
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Birds (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明提供了一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用,涉及壳聚糖纳米粒工艺技术领域。一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,其将亲水性壳聚糖和壳聚糖按比例混合,与三聚磷酸钠溶液按比例进行交联,制得壳聚糖纳米粒。本发明还提供了该具有优良冻干再分散性的壳聚糖纳米粒和其制得的冻干制剂及应用。本发明可以制备得到具有优良冻干再分散性的壳聚糖纳米粒,且在冻干时不使用冻干保护剂依然可以保持壳聚糖纳米粒原有的纳米结构。
Description
技术领域
本发明涉及壳聚糖纳米粒工艺技术领域,具体而言,涉及一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用。
背景技术
离子凝胶法合成壳聚糖纳米粒反应条件温和、制备简单、无需使用有机溶剂,且由于其得到的纳米粒稳定性好、粒径均匀等优势成为最常用的制备方法,特别适合包载蛋白质、核酸、疫苗等大分子生化药物。蛋白因子主要成分为具有各种功能的多肽如PDGF和TGF-β等各种细胞因子。因此用离子凝胶法来合成负载蛋白因子的壳聚糖纳米粒是不二选择。壳聚糖具有良好的透膜能力可以有效地提高蛋白因子的透膜能力,进而提高蛋白因子在应用时的效果。
目前,用于制备壳聚糖纳米粒的壳聚糖为疏水性,其表面氨基之间的氢键作用过强,在冻干后纳米粒之间相互通过氢键交联,形成表面完全疏水的团聚体,导致壳聚糖纳米粒冻干后无法再分散于水中,冻干再分散性极差,限制了壳聚糖纳米粒的工业应用;另外,壳聚糖纳米粒在冻干时需要添加冻干保护剂才能保持壳聚糖纳米粒原有的纳米结构。
发明内容
本发明的第一个目的在于提供一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,可以制备得到具有优良冻干再分散性的壳聚糖纳米粒,且在冻干时不使用冻干保护剂依然可以保持壳聚糖纳米粒原有的纳米结构。
本发明的第二个目的在于提供一种具有优良冻干再分散性的壳聚糖纳米粒,通过制备方法制得的壳聚糖纳米粒,具有优良的冻干再分散性。
本发明的第三个目的在于提供一种壳聚糖纳米粒冻干制剂,其由壳聚糖纳米粒冻干制得。
本发明的第四个目的在于提供一种壳聚糖纳米粒冻干制剂在制备生化药物或护肤品中的应用。
本发明的实施例通过以下技术方案实现:
一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将亲水性壳聚糖和壳聚糖按比例混合形成一定浓度的壳聚糖溶液;
S2:制备一定浓度的三聚磷酸钠溶液;
S3:按一定比例将三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得壳聚糖纳米粒。
进一步地,所述步骤S1中亲水性壳聚糖为乳酸壳聚糖或羧甲基壳聚糖。
进一步地,所述步骤S1中亲水性壳聚糖和壳聚糖的质量比例为5~9:1~5。
进一步地,所述步骤S1制得的壳聚糖溶液的浓度为1~3mg/ml。
进一步地,所述步骤S2中制得的三聚磷酸钠溶液的浓度为1~5mg/ml。
进一步地,所述步骤S3中三聚磷酸钠溶液和壳聚糖溶液的体积比例为1:4~8。
进一步地,所述步骤S2中还包括将亲水药物或蛋白因子溶解于三聚磷酸钠溶液中制得载药三聚磷酸钠溶液,以使步骤S3制得载药壳聚糖纳米粒。
一种由制备方法制备得到的具有优良冻干再分散性的壳聚糖纳米粒或载药壳聚糖纳米粒。
一种壳聚糖纳米粒冻干制剂,由壳聚糖纳米粒冻干制得。
一种壳聚糖纳米粒冻干制剂在制备生化药物或护肤品中的应用。
本发明实施例的技术方案至少具有如下优点和有益效果:
本发明通过亲水性壳聚糖和壳聚糖按比例组装形成壳聚糖纳米粒,制备的壳聚糖纳米粒表面亲水,避免了壳聚糖纳米粒表面氢键的交联,减少纳米粒冻干后的交联现象,大幅提高了壳聚糖纳米粒的冻干再分散性能;且在冻干时不需要使用冻干保护剂,仍然可以保持壳聚糖纳米粒原有的纳米结构。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
下面对本发明实施例提供的一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用进行具体说明。
实施例1
本实施例提供了一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将乳酸壳聚糖和壳聚糖按质量比例为5:5混合形成1mg/ml浓度的壳聚糖溶液;
S2:制备1mg/ml浓度的三聚磷酸钠溶液;
S3:按体积比例为1:6将三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得壳聚糖纳米粒A。
再将制得的壳聚糖纳米粒冻干制得壳聚糖纳米粒冻干制剂A1。
实施例2
本实施例提供了一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将乳酸壳聚糖和壳聚糖按质量比例为7:3混合形成1mg/ml浓度的壳聚糖溶液;
S2:制备1mg/ml浓度的三聚磷酸钠溶液;
S3:按体积比例为1:6将三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得壳聚糖纳米粒B。
再将制得的壳聚糖纳米粒冻干制得壳聚糖纳米粒冻干制剂B1。
实施例3
本实施例提供了一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将乳酸壳聚糖和壳聚糖按质量比例为7:3混合形成1mg/ml浓度的壳聚糖溶液;
S2:制备1mg/ml浓度的三聚磷酸钠溶液,再于三聚磷酸钠溶液中溶解蛋白因子至终浓度1mg/ml,即制得载药三聚磷酸钠溶液;
S3:按体积比例为1:6将载药三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得载药壳聚糖纳米粒C。
再将制得的壳聚糖纳米粒冻干制得壳聚糖纳米粒冻干制剂C1。
实施例4
本实施例提供了一种具有优良冻干再分散性的壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将乳酸壳聚糖和壳聚糖按质量比例为9:1混合形成1mg/ml浓度的壳聚糖溶液;
S2:制备1mg/ml浓度的三聚磷酸钠溶液,再于三聚磷酸钠溶液中溶解蛋白因子至终浓度1mg/ml,即制得载药三聚磷酸钠溶液;
S3:按体积比例为1:6将载药三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得载药壳聚糖纳米粒D。
再将制得的壳聚糖纳米粒冻干制得壳聚糖纳米粒冻干制剂D1。
对比例1
本对比例提供了一种壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将壳聚糖溶解于1%醋酸溶剂中形成1mg/ml浓度的壳聚糖溶液;
S2:制备1mg/ml浓度的三聚磷酸钠溶液,再于三聚磷酸钠溶液中溶解蛋白因子至终浓度1mg/ml,即制得载药三聚磷酸钠溶液;
S4:按体积比例为1:6将载药三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得载药壳聚糖纳米粒M;将载药壳聚糖纳米粒M中按质量比10%混合加入甘露醇。
再将混合加入甘露醇的壳聚糖纳米粒冻干制得壳聚糖纳米粒冻干制剂M1。
对比例2
本对比例提供了一种壳聚糖纳米粒的制备方法,包括以下步骤:
S1:将壳聚糖溶解于1%醋酸溶剂中形成1mg/ml浓度的壳聚糖溶液;
S2:制备1mg/ml浓度的三聚磷酸钠溶液,再于三聚磷酸钠溶液中溶解蛋白因子至终浓度1mg/ml,即制得载药三聚磷酸钠溶液;
S3:按体积比例为1:6将载药三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得载药壳聚糖纳米粒G。
再将制得的壳聚糖纳米粒冻干制得壳聚糖纳米粒冻干制剂G1。
实验例1
取等量的实施例1~4制得的壳聚糖纳米粒A~D和对比例1~2制得的壳聚糖纳米粒M、G,检测各壳聚糖纳米粒的多分散指数;再将等量的实施例1~4制得的壳聚糖纳米粒冻干制剂A1~D1和对比例1~2制得的壳聚糖纳米粒冻干制剂M1、G1分别用水溶液复溶,检测各壳聚糖纳米粒冻干制剂复溶溶液的多分散指数;结果如表1所示。
表1 多分散指数
由表1可知,本发明实施例1~4制得的壳聚糖纳米粒A~D的粒径和实施例1~4制得的壳聚糖纳米粒冻干制剂A1~D1复溶溶液的多分散指数变化不大,且均较小,在0.4以下,而对比例1~2制得的壳聚糖纳米粒冻干制剂M1、G1复溶溶液的粒径比对比例1~2制得的壳聚糖纳米粒M、G的多分散指数增大较多,且超过0.6;说明本发明方法制得的壳聚糖纳米粒冻干制剂复溶后粒径分布范围仍然较集中,说明本发明方法制得的壳聚糖纳米粒的冻干再分散性能较优良。
实验例2
取等量的实施例1~4制得的壳聚糖纳米粒A~D和对比例1~2制得的壳聚糖纳米粒M、G,检测各壳聚糖纳米粒的粒径;再将等量的实施例1~4制得的壳聚糖纳米粒冻干制剂A1~D1和对比例1~2制得的壳聚糖纳米粒冻干制剂M1、G1分别用水溶液复溶,检测各壳聚糖纳米粒冻干制剂复溶溶液的粒径;结果如表2所示。
表2 粒径
由表2可知,本发明实施例1~4制得的壳聚糖纳米粒A~D的粒径和实施例1~4制得的壳聚糖纳米粒冻干制剂A1~D1复溶溶液的粒径变化不大,对比例1制得的壳聚糖纳米粒M在冻干时采用了甘露醇冻干保护剂,其制得的壳聚糖纳米粒冻干制剂M1复溶溶液的粒径变化不大,而对比例2制得的壳聚糖纳米粒G在冻干时未采用冻干保护剂,其制得的壳聚糖纳米粒冻干制剂G1复溶溶液的粒径比对比例2制得的壳聚糖纳米粒G的粒径增大较多;说明本发明方法在冻干时不使用冻干保护剂制得的壳聚糖纳米粒仍然可以保持壳聚糖纳米粒原有的纳米结构。
综上,通过亲水性壳聚糖和壳聚糖按比例组装形成壳聚糖纳米粒,制备的壳聚糖纳米粒具有优良的冻干再分散性能,且在冻干时不需要使用冻干保护剂,仍然可以保持壳聚糖纳米粒原有的纳米结构。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (5)
1.一种壳聚糖纳米粒的制备方法,其特征在于,包括以下步骤:
S1:将亲水性壳聚糖和壳聚糖按比例混合形成壳聚糖溶液;
S2:制备三聚磷酸钠溶液;
S3:将三聚磷酸钠溶液缓慢滴加到壳聚糖溶液进行交联,制得壳聚糖纳米粒;
所述步骤S1中亲水性壳聚糖为乳酸壳聚糖;
所述步骤S1中亲水性壳聚糖和壳聚糖的质量比例为5~9:1~5;
所述步骤S1制得的壳聚糖溶液的浓度为1~3mg/ml;
所述步骤S2中制得的三聚磷酸钠溶液的浓度为1~5mg/ml;
所述步骤S3中三聚磷酸钠溶液和壳聚糖溶液的体积比例为1:4~8。
2.根据权利要求1所述的壳聚糖纳米粒的制备方法,其特征在于,所述步骤S2中还包括将亲水药物或蛋白因子溶解于三聚磷酸钠溶液中制得载药三聚磷酸钠溶液,以使步骤S3制得载药壳聚糖纳米粒。
3.一种由权利要求1或2所述的制备方法制备得到的壳聚糖纳米粒或载药壳聚糖纳米粒。
4.一种壳聚糖纳米粒冻干制剂,其特征在于,由权利要求1或2所述的制备方法制得的壳聚糖纳米粒或载药壳聚糖纳米粒或权利要求3所述的壳聚糖纳米粒或载药壳聚糖纳米粒冻干制得。
5.一种权利要求4所述的壳聚糖纳米粒冻干制剂在制备生化药物或护肤品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210009248.9A CN114366816B (zh) | 2022-01-05 | 2022-01-05 | 一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210009248.9A CN114366816B (zh) | 2022-01-05 | 2022-01-05 | 一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114366816A CN114366816A (zh) | 2022-04-19 |
CN114366816B true CN114366816B (zh) | 2023-06-20 |
Family
ID=81141955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210009248.9A Active CN114366816B (zh) | 2022-01-05 | 2022-01-05 | 一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114366816B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024182500A1 (en) * | 2023-02-28 | 2024-09-06 | Onelogy Inc. | Dried cosmetic preparation for rehydration and use |
CN116807996A (zh) * | 2023-07-05 | 2023-09-29 | 宁夏医科大学总医院 | 负载β-酸的壳聚糖纳米材料及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005075957A (ja) * | 2003-09-01 | 2005-03-24 | Kyowa Technos:Kk | 水溶性キトサン |
CN102407089A (zh) * | 2011-10-19 | 2012-04-11 | 中国海洋大学 | 一种具有核壳结构的壳聚糖复合纳/微米胶囊的制备方法 |
CN106727319A (zh) * | 2017-01-09 | 2017-05-31 | 广州润虹医药科技有限公司 | 一种妇科泡沫剂及其制备方法 |
CN109847097A (zh) * | 2018-12-10 | 2019-06-07 | 安徽徽科生物工程技术有限公司 | 天然生物修复膜、其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100578382B1 (ko) * | 2004-07-16 | 2006-05-11 | 나재운 | 항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법 |
CN100341933C (zh) * | 2005-03-21 | 2007-10-10 | 上海美宝生命科技有限公司 | 具有吸水膨胀性能的羧甲基壳聚糖海绵及制法和用途 |
CN101139404A (zh) * | 2007-10-26 | 2008-03-12 | 大连利健生物技术开发股份有限公司 | 壳聚糖乳酸盐的制备方法 |
CA2940012C (en) * | 2014-02-20 | 2023-08-01 | Ortho Regenerative Technologies Inc. | Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair |
US20210322225A1 (en) * | 2017-12-29 | 2021-10-21 | Sree Chitra Tirunal Institute For Medical Sciences And Technology | Lint Free Crosslinked Chitosan-PVA Sponge as an Absorbent Wound Dressing and Method of Preparation Thereof |
-
2022
- 2022-01-05 CN CN202210009248.9A patent/CN114366816B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005075957A (ja) * | 2003-09-01 | 2005-03-24 | Kyowa Technos:Kk | 水溶性キトサン |
CN102407089A (zh) * | 2011-10-19 | 2012-04-11 | 中国海洋大学 | 一种具有核壳结构的壳聚糖复合纳/微米胶囊的制备方法 |
CN106727319A (zh) * | 2017-01-09 | 2017-05-31 | 广州润虹医药科技有限公司 | 一种妇科泡沫剂及其制备方法 |
CN109847097A (zh) * | 2018-12-10 | 2019-06-07 | 安徽徽科生物工程技术有限公司 | 天然生物修复膜、其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
壳聚糖纳米粒子的制备及其在医药领域的应用;李高荣;欧阳茜茜;李思东;黄娜;陈法锦;李普旺;罗荣琼;;药学研究(第01期) * |
Also Published As
Publication number | Publication date |
---|---|
CN114366816A (zh) | 2022-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114366816B (zh) | 一种具有优良冻干再分散性的壳聚糖纳米粒、冻干制剂及其制备方法和应用 | |
Chen et al. | Designing chitosan-dextran sulfate nanoparticles using charge ratios | |
Anal et al. | Preparation and characterization of nanoparticles formed by chitosan–caseinate interactions | |
CN110897161B (zh) | 一种高荷载姜黄素的大豆多肽基纳米颗粒及其pH驱动制备方法与应用 | |
Algharib et al. | Preparation of chitosan nanoparticles by ionotropic gelation technique: Effects of formulation parameters and in vitro characterization | |
Takka et al. | Evaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterization | |
DE60035211T2 (de) | Mikrokugeln mit kontinuierlicher Freisetzung | |
JP5617241B2 (ja) | 新規なナノ粒子 | |
Masalova et al. | Alginate and chitosan gel nanoparticles for efficient protein entrapment | |
US20010051189A1 (en) | Application of nanoparticles based on hydrophilic polymers as pharamaceutical forms | |
US11737981B2 (en) | Cellulosic polymer nanoparticles and methods of forming them | |
IE62111B1 (en) | Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase and process for preparing a dispersion of the powdered polymer | |
US20090214633A1 (en) | Nanoparticles with lipid core and polymer shell structures for protein drug delivery prepared by nanoencapsulation | |
CN108480650A (zh) | 一种液态金属纳米颗粒及其制备方法 | |
EP0860166A1 (en) | Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms | |
US20070122484A1 (en) | Parenterally administrable microparticles | |
CN113575951A (zh) | 一种淀粉基双负载功能纳米颗粒、其制备方法及应用 | |
CN113599367B (zh) | 具有核壳结构的蛋白微粒及其制备方法和用途 | |
Sahu et al. | Design and evaluation of a nanoparticulate system prepared by biodegradable polymers for oral administration of protein drugs | |
CN1931129A (zh) | 一种可生物降解聚合物磁性载药微球的制备方法 | |
CN111269443B (zh) | 基于动态化学键交联的纳米凝胶及其制备方法与应用 | |
Chakraborty et al. | STABILIZATION OF CALCIUM SENSITIVE PLANT PROTEINS BY κ‐CARRAGEENAN | |
CN115777914A (zh) | 一种基于脱支淀粉-玉米醇溶蛋白复合颗粒包埋营养功能成分的缓释递送载体及其制备方法 | |
Çetin et al. | Preparation and characterization of BSA-loaded alginate microspheres | |
Nayak et al. | Transport of curcumin from cross-linked chitosan matrices: A comparative study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |